Autopsy report · NCT03481894

Study to Assess Safety and Efficacy of Kabiven® in Pediatric Patients 2 to 16 Years of Age

Cause of deathRegulatory or ethics Automatic label, confidence 0.9, unverified. How labels are made.

“FDA released Fresenius Kabi from this post marketing requirement on 07/16/2019.”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 4
Sponsor: Fresenius Kabi
Sponsor type: Industry
Conditions: Malnutrition
Interventions: Kabiven®; Compounded standard parenteral nutrition
Participants: 0
Sites: 2
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.